| Systematic evaluation of differential splicing tools for RNA-seq studies A Mehmood, A Laiho, MS Venäläinen, AJ McGlinchey, N Wang, LL Elo Briefings in bioinformatics 21 (6), 2052-2065, 2020 | 159 | 2020 |
| Exposure to environmental contaminants is associated with altered hepatic lipid metabolism in non-alcoholic fatty liver disease P Sen, S Qadri, PK Luukkonen, O Ragnarsdottir, A McGlinchey, S Jäntti, ... Journal of Hepatology 76 (2), 283-293, 2022 | 145 | 2022 |
| Deep learning meets metabolomics: A methodological perspective P Sen, S Lamichhane, VB Mathema, A McGlinchey, AM Dickens, ... Briefings in Bioinformatics 22 (2), 1531-1542, 2021 | 74 | 2021 |
| Innate Immune Response Precedes Mycobacterium leprae–Induced Reprogramming of Adult Schwann Cells T Masaki, A McGlinchey, J Cholewa-Waclaw, J Qu, SR Tomlinson, ... Cellular Reprogramming (Formerly" Cloning and Stem Cells") 16 (1), 9-17, 2014 | 63 | 2014 |
| Prenatal exposure to perfluoroalkyl substances modulates neonatal serum phospholipids, increasing risk of type 1 diabetes A McGlinchey, T Sinioja, S Lamichhane, P Sen, J Bodin, H Siljander, ... Environment International 143, 105935, 2020 | 44 | 2020 |
| Metabolic signatures across the full spectrum of nonalcoholic fatty liver disease AJ McGlinchey, O Govaere, D Geng, V Ratziu, M Allison, J Bousier, ... JHEP Reports, 2022 | 41 | 2022 |
| Systems biology approaches to study lipidomes in health and disease MA Alves, S Lamichhane, A Dickens, A McGlinchey, HC Ribeiro, P Sen, ... Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids …, 2021 | 37 | 2021 |
| Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance K Johnson, PJ Leary, O Govaere, MJ Barter, SH Charlton, SJ Cockell, ... JHEP Reports 4 (2), 100409, 2022 | 35 | 2022 |
| Metabolic Signatures of the Exposome—Quantifying the Impact of Exposure to Environmental Chemicals on Human Health M Orešič, A McGlinchey, CE Wheelock, T Hyötyläinen Metabolites 10 (11), 454, 2020 | 30 | 2020 |
| Reprogramming diminishes retention of Mycobacterium leprae in Schwann cells and elevates bacterial transfer property to fibroblasts T Masaki, A McGlinchey, SR Tomlinson, J Qu, A Rambukkana F1000Research 2, 2013 | 22 | 2013 |
| Perfluoroalkyl substances are increased in patients with late-onset ulcerative colitis and induce intestinal barrier defects ex vivo in murine intestinal tissue F Fart, S Salihović, A McGlinchey, MG Gareau, M Orešič, J Halfvarson, ... Scandinavian journal of gastroenterology 56 (11), 1286-1295, 2021 | 16 | 2021 |
| Quantitative modeling of human liver reveals dysregulation of glycosphingolipid pathways in nonalcoholic fatty liver disease P Sen, O Govaere, T Sinioja, A McGlinchey, D Geng, V Ratziu, ... Iscience 25 (9), 2022 | 14 | 2022 |
| Prenatal exposure to environmental chemicals modulates serum phospholipids in newborn infants, increasing later risk of type 1 diabetes A McGlinchey, T Sinioja, S Lamichhane, J Bodin, H Siljander, D Geng, ... bioRxiv, 588350, 2019 | 14 | 2019 |
| PASI: A novel pathway method to identify delicate group effects MK Jaakkola, AJ McGlinchey, R Klen, LL Elo PloS one 13 (7), e0199991, 2018 | 6 | 2018 |
| The effects of bisphenol A on in-vitro cell viability of mammalian cell line by neutral red assay AJ McGlinchey University of Plymouth, 2009 | 6 | 2009 |
| Potential Transdiagnostic Lipid Mediators of Inflammatory Activity in Individuals With Serious Mental Illness U Hylén, A McGlinchey, M Orešič, S Bejerot, MB Humble, E Särndahl, ... Frontiers in Psychiatry, 2034, 2021 | 4 | 2021 |
| Quantitative genome-scale analysis of human liver reveals dysregulation of glycosphingolipid pathways in progressive nonalcoholic fatty liver disease P Sen, O Govaere, T Sinioja, A McGlinchey, D Geng, V Ratziu, ... medRxiv, 2021.02. 09.21251354, 2021 | 3 | 2021 |
| In utero exposures to perfluoroalkyl substances and the human fetal liver metabolome in Scotland: a cross-sectional study T Hyötyläinen, A McGlinchey, S Salihovic, A Schubert, A Douglas, ... The Lancet Planetary Health 8 (1), e5-e17, 2024 | 1 | 2024 |
| Genome-scale metabolic modeling of human hepatocytes reveals dysregulation of glycosphingolipid pathways in progressive non-alcoholic fatty liver disease P Sen, O Govaere, T Sinioja, AJ McGlinchey, D Geng, V Ratziu, ... Journal of Hepatology 75 (Suppl. 2), S256-S256, 2021 | | 2021 |
| The Metabolomics of Non-Alcoholic Fatty Liver Disease: Of Networks and Biomarkers AJ McGlinchey, D Geng, O Govaere, V Ratziu, E Bugianesi, ... Journal of Hepatology 75 (Suppl. 2), S579-S580, 2021 | | 2021 |
